Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5322 ARTÍCULOS , VIENDO DEL 1786 AL 1800

Genetic meta-analysis of levodopa induced dyskinesia in Parkinson's disease

Martinez-Carrasco A, Real R, Lawton M, Iwaki H, Tan MMX, Wu L, Williams NM, Carroll C, Hu MTM, Grosset DG, Hardy J, Ryten M, Foltynie T, Ben-Shlomo Y, Shoai M, Morris HR.

medRxiv [Preprint]. 2023 May 30:2023.05.24.23290362. doi: 10.1101/2023.05.24.23290362.

Salivary Biomarkers: Noninvasive Ways for Diagnosis of Parkinson's Disease

Salaramoli S, Joshaghani HR, Hashemy SI.

Neurol Res Int. 2023 Jul 3;2023:3555418. doi: 10.1155/2023/3555418. eCollection 2023.

Potential role of N6-methyladenosine modification in the development of Parkinson's disease

Zhou J, Han Y, Hou R.

Front Cell Dev Biol. 2023 Dec 13;11:1321995. doi: 10.3389/fcell.2023.1321995. eCollection 2023.

Planimetric and Volumetric Brainstem MRI Markers in Progressive Supranuclear Palsy, Multiple System Atrophy, and Corticobasal Syndrome. A Systematic Review and Meta-Analysis

Brinia ME, Kapsali I, Giagkou N, Constantinides VC.

Neurol Int. 2023 Dec 19;16(1):1-19. doi: 10.3390/neurolint16010001.

Assessing causal relationship between circulating cytokines and age-related neurodegenerative diseases: a bidirectional two-sample Mendelian randomization analysis

Yin Z, Chen J, Xia M, Zhang X, Li Y, Chen Z, Bao Q, Zhong W, Yao J, Wu K, Zhao L, Liang F.

Sci Rep. 2023 Jul 29;13(1):12325. doi: 10.1038/s41598-023-39520-9.

Pathological Pathways and Alpha-Synuclein in Parkinson's Disease: A View from the Periphery

Basellini MJ, Kothuis JM, Comincini A, Pezzoli G, Cappelletti G, Mazzetti S.

Front Biosci (Landmark Ed). 2023 Feb 23;28(2):33. doi: 10.31083/j.fbl2802033.

Preclinical Evidence-based Review on Therapeutic Potential of Eugenol for the Treatment of Brain Disorders

Goyal A, Solanki A, Verma A.

Curr Mol Med. 2023;23(5):390-400. doi: 10.2174/1566524022666220525145521.

Does Black vs. White race affect practitioners' appraisal of Parkinson's disease?

Harris S, Narayanan NS, Tranel D.

NPJ Parkinsons Dis. 2023 Jul 7;9(1):106. doi: 10.1038/s41531-023-00549-2.

Levodopa, homocysteine and Parkinson's disease: What's the problem?

Ahlskog JE.

Parkinsonism Relat Disord. 2023 Apr;109:105357. doi: 10.1016/j.parkreldis.2023.105357. Epub 2023 Mar 6.

Turning When Using Smartphone in Persons With and Those Without Neurologic Conditions: Observational Study

Bianchini E, Warmerdam E, Romijnders R, Stürner KH, Baron R, Heinzel S, Pontieri FE, Hansen C, Maetzler W.

J Med Internet Res. 2023 Mar 30;25:e41082. doi: 10.2196/41082.

The Impact of Polypharmacy on Management of Lower Urinary Tract Symptoms in Parkinson's Disease

Saraf U, Batla A, Sakakibara R, Panicker JN.

Drugs Aging. 2023 Oct;40(10):909-917. doi: 10.1007/s40266-023-01060-2. Epub 2023 Aug 31.

An Explainable Geometric-Weighted Graph Attention Network for Identifying Functional Networks Associated with Gait Impairment

Nerrise F, Zhao Q, Poston KL, Pohl KM, Adeli E.

ArXiv [Preprint]. 2023 Jul 24:arXiv:2307.13108v1.

Loss of Progranulin Results in Increased Pan-Cathepsin Activity and Reduced LAMP1 Lysosomal Protein

Anderson A, Tansey MG.

bioRxiv [Preprint]. 2023 Jul 16:2023.07.15.549151. doi: 10.1101/2023.07.15.549151.

Butyrate protects and synergizes with nicotine against iron- and manganese-induced toxicities in cell culture: Implications for neurodegenerative diseases

Tizabi Y, Getachew B, Aschner M.

Res Sq [Preprint]. 2023 Oct 5:rs.3.rs-3389904. doi: 10.21203/rs.3.rs-3389904/v1.

Cardiac 18F-Dopamine Positron Emission Tomography Predicts the Type of Phenoconversion of Pure Autonomic Failure

Lenka A, Isonaka R, Holmes C, Goldstein DS.

Res Sq [Preprint]. 2023 Jul 17:rs.3.rs-3157807. doi: 10.21203/rs.3.rs-3157807/v1.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias